A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.

NCT01169714 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 0.1 mg PF-04995274
DRUG: 1 mg PF-04995274
DRUG: 10 mg PF-04995274
DRUG: 15 mg PF-04995274
DRUG: 1.0 mg PF-04995274
DRUG: 15 mg PF-04995274

Sponsor

Pfizer